Category Archives: Hepatocellular Carcinoma, Viral Hepatitis, HCV, HBV, Liver Cancer, Cirrhosis
Liver disease has emerged as a major cause of morbidity and mortality in individuals infected with HIV, including those infected with HBV and HCV. The HIV & Liver Disease 2016 conference is designed to address the increasingly prevalent clinical issues and challenges associated with HIV and liver disease,
U.Miami School of Medicine Awarded $2.5 Million Dollar NIH Award with Emmanuel Thomas, M.D., Ph.D. to help South Florida Community.
A team of Miller school specialists including Emmanuel Thomas, M.D., Ph.D., assistant professor of the Sylvester Comprehensive Cancer Center and the Schiff Center for Liver Diseases and Miami CTSI KL2 Scholar, Daniel Sussman, associate professor of clinical medicine in the Division of Gastroenterology, and Sonjia Kenya, Ed.D., M.S., M.A., assistant research professor of medicine, Director of Community Health Programs at Sylvester’s Jay Weiss Institute for Health Equity, and Education and Research Officer at the Miller School’s Office of Diversity and Multiculturalism, have developed the multi-modal strategy for the early detection and prevention of four health priority conditions: Hepatitis C Virus (HCV), colorectal cancer, Human Immunodeficiency Virus (HIV) and cervical cancer.
Dr. Schiff, Leonard Miller Professor of Medicine, Dr. Nasser Ibrahim Al-Rashid chair in the Division of Hepatology, the director of the Schiff Center for Liver Diseases, and the director of the Hepatology Research Laboratory at the Miller School of Medicine, received the Distinguished Faculty Scholar Award, presented by Emmanuel Thomas, M.D., Ph.D., an assistant professor at Sylvester Comprehensive Cancer Center.
Dr. Thomas Receives Travel Award from the Miami CFAR to Attend the 2015 Liver Meeting (AASLD) in San Francisco.
The Miami Clinical and Translational Science Institute (CTSI) at the University of Miami has selected Emmanuel Thomas, M.D., Ph.D., assistant professor of cell biology, to be its newest Mentored Translational Research Scholar.
This KL2 program helps junior faculty develop successful careers as independent investigators by providing up to three years of renewable annual funds including 75 percent salary support for protected research time and additional funds to support research expenses and research-related travel.
Thomas will also benefit from an individualized career development plan, mentorship, educational programs, experiential training with established faculty researchers, and access to CTSI experts in epidemiology, research design, regulatory support, ethics and biostatistics.
To facilitate this innovative project on HIV pathogenesis, mentorship will be provided by Savita Pahwa, M.D., professor of microbiology and immunology, pediatrics and medicine, Director of the Miami Center for AIDS Research (CFAR) and Associate Director of the HIV/AIDS Institute, and Mario Stevenson, Ph.D., professor of medicine, Chief of the Division of Infectious Diseases in the Department of Medicine, Co-Director of the Center for AIDS Research and Director of the HIV/AIDS Institute.
Thomas will use his grant to study ways to minimize the development and progression of liver disease and liver cancer in patients that are coinfected with both HIV and Hepatitis C.
“Approximately 20 percent of individuals infected with HIV are also infected with Hepatitis C, and liver disease is now a major killer of HIV infected patients. Infection by both of these viruses significantly impacts our South Florida community,” said Thomas. “This project will identify new molecular targets that can be used therapeutically to prevent liver disease and liver cancer in coinfected patients.”
Raised in Miami-Dade County and a 2007 graduate of the Miller School of Medicine, Thomas has a strong commitment to improving the health of the local community. He says his award and the opportunity to collaborate with the CTSI will help advance two programs that are important to him.
The first is a translational research program, which aims at preventing liver disease and hepatocellular carcinoma. It leverages resources and clinical/scientific expertise from the Miami CTSI, the Schiff Center for Liver Diseases, the Sylvester Comprehensive Cancer Center and the Miami Center for AIDS Research.
The second is a community screening program that identifies Hepatitis C infected individuals and links them to care. It also pairs uninsured patients with assistance programs that subsidize the cost of medications.
The Mentored Translational Research Scholars program is managed by the Miami CTSI’s Research Education and Career Development program and directed by Gwendolyn Scott, M.D., professor of pediatrics and Director of the Division of Pediatric Infectious Disease and Immunology.